Who is eligible for clinical trial NCT03899155?

Participants must meet protocol criteria for Cancer. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT03899155 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-07-27

Pan Tumor Rollover Study (NCT03899155)

Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies

🟢 Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Bristol-Myers Squibb

🩺 Plain-English Summary (8th-Grade Level)

Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

Who can join: Review the eligibility criteria below.

Location: Local Institution - 0220 — Huntsville, Alabama

Age range: 18 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (399 Sites)

Showing the first 25 of 399 sites.

Local Institution - 0220 — Huntsville, Alabama
University of Arizona College of Medicine — Tucson, Arizona
Innovative Clinical Research Institute — Lynwood, California
Local Institution — San Francisco, California
Local Institution - 0099 — San Francisco, California
Local Institution - 0233 — Aurora, Colorado
Local Institution - 0095 — New Haven, Connecticut
Local Institution - 0088 — Washington D.C., District of Columbia
Florida Cancer Affiliates — Ocala, Florida
Local Institution — Orlando, Florida
Local Institution - 0024 — Tampa, Florida
Local Institution - 0105 — Chicago, Illinois
Local Institution — Maywood, Illinois
Local Institution - 0279 — Park Ridge, Illinois
Local Institution - 0186 — Westwood, Kansas
Local Institution - 0165 — Wichita, Kansas
University of Louisville-James Graham Brown Cancer Center — Louisville, Kentucky
Local Institution - 0092 — Baltimore, Maryland
Local Institution - 0039 — Boston, Massachusetts
Dana_Farber Cancer Institute (DFCI) — Boston, Massachusetts
Local Institution - 0081 — Boston, Massachusetts
Local Institution - 0143 — Ann Arbor, Michigan
Local Institution - 0100 — Minneapolis, Minnesota
Local Institution — St Louis, Missouri
Local Institution - 0205 — Omaha, Nebraska

📞 Contact the Study Coordinator

Phone: (855) 907-3286

Email: Clinical.Trials@bms.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cancer

Ovarian Tissue Cryopreservation in Children — Rochester, Minnesota
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study — Aurora, Colorado
Ex Onc SLED: A Study Utilizing A Weighted Sled for Horizontal Resistance Training — Pittsburgh, Pennsylvania
An Internet-based Program to Help Cancer Survivors Manage Pain — Fort Smith, Arkansas
Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors — Toronto, Ontario
Researching the Effect of Aerobic Exercise on Cancer — Los Angeles, California

Explore by condition: All Cancer clinical trials

💡 How to Participate

Check the checklist above to see if you may qualify.
Contact the study coordinator using the phone/email above.
Ask about the visit schedule, what is covered at no cost, and any travel support.
Confirm with your own doctor before making a decision.

🏛️ View Official NIH Record ↗